Ana Slipicevic
- Co-authors
- Viví Ann FlørenesBen DavidsonRuth HolmAnne Katrine Ree RosnesElisabeth EmilsenMartina L. SkredeClaes G. TropéArild Holth
- Topics
- Multiple Myeloma Research and Treatments (7 papers)Melanoma and MAPK Pathways (7 papers)Peptidase Inhibition and Analysis (5 papers)
- Journals
- BloodPLoS ONECancer Research
- Partner nations
- NorwayUnited StatesFinland
In The Last Decade
Ana Slipicevic
37 papers receiving 802 citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 623
- Oncology 311
- Cancer Research 152
- Immunology 87
- Pathology and Forensic Medicine 67
Countries citing papers authored by Ana Slipicevic
This map shows the geographic impact of Ana Slipicevic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Slipicevic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Slipicevic more than expected).
Fields of papers citing papers by Ana Slipicevic
This network shows the impact of papers produced by Ana Slipicevic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Slipicevic. The network helps show where Ana Slipicevic may publish in the future.
Co-authorship network of co-authors of Ana Slipicevic
This figure shows the co-authorship network connecting the top 25 collaborators of Ana Slipicevic. A scholar is included among the top collaborators of Ana Slipicevic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Slipicevic. Ana Slipicevic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 39 | |
| 3 | 3 | |
| 4 | 9 | |
| 5 | 6 | |
| 6 | 10 | |
| 7 | 8 | |
| 8 | 13 | |
| 9 | 40 | |
| 10 | 4 | |
| 11 | 14 | |
| 12 | 12 | |
| 13 | 122 | |
| 14 | 19 | |
| 15 | 61 | |
| 16 | 91 | |
| 17 | 44 | |
| 18 | 27 | |
| 19 | 71 | |
| 20 | 11 |
About Ana Slipicevic
Ana Slipicevic is a scholar working on Oncology, Hematology and Molecular Biology, having authored 37 papers that have together received 823 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Melanoma and MAPK Pathways (7 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Oncology (311 citations), Cancer Research (152 citations) and Molecular Biology (623 citations). Ana Slipicevic has collaborated with scholars based in Norway, United States and Finland. Frequent co-authors include Viví Ann Flørenes, Ben Davidson, Ruth Holm, Anne Katrine Ree Rosnes, Elisabeth Emilsen, Martina L. Skrede, Claes G. Tropé, Arild Holth, Per J. Bøhler and Mai T. Nguyen. Their work appears in journals such as Blood, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.